ReP USP - Resultado da busca

Trabalho de evento-resumo
Strategies for overcoming toxicity and resistance in melanoma progression and in adaptative resistance to braf inhibitors using ADK modulation (2022)
Silva, Julia Rezende da ; Oliveira, Erica Aparecida de ; Carvalho, Larissa Anastácio da Costa ; Maria-Engler, Silvya Stuchi
Source: Livro de Resumos. Conference titles: Congresso Brasileiro de Toxicologia/CBTox. Unidade: FCF
Subjects: MELANOMA, ADENOSINA, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Julia Rezende da et al. Strategies for overcoming toxicity and resistance in melanoma progression and in adaptative resistance to braf inhibitors using ADK modulation. 2022, Anais.. São Paulo: Sociedade Brasileira de Toxicologia, 2022. Disponível em: https://cbtox2021.com.br/XXII_CBTOX.pdf. Acesso em: 27 set. 2024.
APA
Silva, J. R. da, Oliveira, E. A. de, Carvalho, L. A. da C., & Maria-Engler, S. S. (2022). Strategies for overcoming toxicity and resistance in melanoma progression and in adaptative resistance to braf inhibitors using ADK modulation. In Livro de Resumos. São Paulo: Sociedade Brasileira de Toxicologia. Recuperado de https://cbtox2021.com.br/XXII_CBTOX.pdf
NLM
Silva JR da, Oliveira EA de, Carvalho LA da C, Maria-Engler SS. Strategies for overcoming toxicity and resistance in melanoma progression and in adaptative resistance to braf inhibitors using ADK modulation [Internet]. Livro de Resumos. 2022 ;[citado 2024 set. 27 ] Available from: https://cbtox2021.com.br/XXII_CBTOX.pdf
Vancouver
Silva JR da, Oliveira EA de, Carvalho LA da C, Maria-Engler SS. Strategies for overcoming toxicity and resistance in melanoma progression and in adaptative resistance to braf inhibitors using ADK modulation [Internet]. Livro de Resumos. 2022 ;[citado 2024 set. 27 ] Available from: https://cbtox2021.com.br/XXII_CBTOX.pdf
Parte de monografia/livro
Organotypic models in drug development tumor models and cancer systems biology for the investigation of anticancer drugs and resistance development (2021)
Oliveira, Erica Aparecida de ; Goding, Colin R; Maria-Engler, Silvya Stuchi
Source: Organotypic Models in Drug Development. Unidade: FCF
Subjects: NEOPLASIAS, RESISTÊNCIA MICROBIANA ÀS DROGAS, GENÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Erica Aparecida de e GODING, Colin R e MARIA-ENGLER, Silvya Stuchi. Organotypic models in drug development tumor models and cancer systems biology for the investigation of anticancer drugs and resistance development. Organotypic Models in Drug Development. Tradução . Cham: Springer, 2021. . Disponível em: https://doi.org/10.1007/978-3-030-70063-8. Acesso em: 27 set. 2024.
APA
Oliveira, E. A. de, Goding, C. R., & Maria-Engler, S. S. (2021). Organotypic models in drug development tumor models and cancer systems biology for the investigation of anticancer drugs and resistance development. In Organotypic Models in Drug Development. Cham: Springer. doi:10.1007/978-3-030-70063-8
NLM
Oliveira EA de, Goding CR, Maria-Engler SS. Organotypic models in drug development tumor models and cancer systems biology for the investigation of anticancer drugs and resistance development [Internet]. In: Organotypic Models in Drug Development. Cham: Springer; 2021. [citado 2024 set. 27 ] Available from: https://doi.org/10.1007/978-3-030-70063-8
Vancouver
Oliveira EA de, Goding CR, Maria-Engler SS. Organotypic models in drug development tumor models and cancer systems biology for the investigation of anticancer drugs and resistance development [Internet]. In: Organotypic Models in Drug Development. Cham: Springer; 2021. [citado 2024 set. 27 ] Available from: https://doi.org/10.1007/978-3-030-70063-8
Artigo de periodico
TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors (2021)
Oliveira, Erica Aparecida de ; Chauhan, Jagat; Silva, Julia Rezende da; Carvalho, Larissa Anastácio da Costa ; Dias, Diogo; Carvalho, Danielle Gonçalves de; Watanabe, Luis Roberto Masao ; Rebecca, Vito William; Mills, Gordon ; Lu, Yiling ; Silva, Aloísio Souza Felipe da; Consolaro, Marcia Edilaine Lopes ; Herlyn, Meenhard ; Possik, Patricia Abrão ; Goding, Colin R; Maria-Engler, Silvya Stuchi
Source: Pharmacological Research. Unidades: FM, FCF
Subjects: MELANOMA, METÁSTASE NEOPLÁSICA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Erica Aparecida de et al. TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors. Pharmacological Research, v. 173, p. 1-11 art. 105911, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2021.105911. Acesso em: 27 set. 2024.
APA
Oliveira, E. A. de, Chauhan, J., Silva, J. R. da, Carvalho, L. A. da C., Dias, D., Carvalho, D. G. de, et al. (2021). TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors. Pharmacological Research, 173, 1-11 art. 105911. doi:10.1016/j.phrs.2021.105911
NLM
Oliveira EA de, Chauhan J, Silva JR da, Carvalho LA da C, Dias D, Carvalho DG de, Watanabe LRM, Rebecca VW, Mills G, Lu Y, Silva ASF da, Consolaro MEL, Herlyn M, Possik PA, Goding CR, Maria-Engler SS. TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors [Internet]. Pharmacological Research. 2021 ; 173 1-11 art. 105911.[citado 2024 set. 27 ] Available from: https://doi.org/10.1016/j.phrs.2021.105911
Vancouver
Oliveira EA de, Chauhan J, Silva JR da, Carvalho LA da C, Dias D, Carvalho DG de, Watanabe LRM, Rebecca VW, Mills G, Lu Y, Silva ASF da, Consolaro MEL, Herlyn M, Possik PA, Goding CR, Maria-Engler SS. TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors [Internet]. Pharmacological Research. 2021 ; 173 1-11 art. 105911.[citado 2024 set. 27 ] Available from: https://doi.org/10.1016/j.phrs.2021.105911
Artigo de periodico
Metalloproteinases suppression driven by the curcumin analog dm-1 modulates invasion in braf-resistant melanomas (2020)
Souza, Nayane de; Oliveira, Erica Aparecida de; Flores, Fernanda Faião; Pimenta, Luciana de Araujo; Quincoces, José A. P; Sampaio, Sandra C; Maria-Engler, Silvya Stuchi
Source: Anti-Cancer Agents in Medicinal Chemistry. Unidade: FCF
Subjects: MELANOMA, AÇAFRÃO, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Nayane de et al. Metalloproteinases suppression driven by the curcumin analog dm-1 modulates invasion in braf-resistant melanomas. Anti-Cancer Agents in Medicinal Chemistry, v. 20, p. 1038-1050, 2020Tradução . . Disponível em: https://doi.org/10.2174/1871520620666200218111422. Acesso em: 27 set. 2024.
APA
Souza, N. de, Oliveira, E. A. de, Flores, F. F., Pimenta, L. de A., Quincoces, J. A. P., Sampaio, S. C., & Maria-Engler, S. S. (2020). Metalloproteinases suppression driven by the curcumin analog dm-1 modulates invasion in braf-resistant melanomas. Anti-Cancer Agents in Medicinal Chemistry, 20, 1038-1050. doi:10.2174/1871520620666200218111422
NLM
Souza N de, Oliveira EA de, Flores FF, Pimenta L de A, Quincoces JAP, Sampaio SC, Maria-Engler SS. Metalloproteinases suppression driven by the curcumin analog dm-1 modulates invasion in braf-resistant melanomas [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2020 ; 20 1038-1050.[citado 2024 set. 27 ] Available from: https://doi.org/10.2174/1871520620666200218111422
Vancouver
Souza N de, Oliveira EA de, Flores FF, Pimenta L de A, Quincoces JAP, Sampaio SC, Maria-Engler SS. Metalloproteinases suppression driven by the curcumin analog dm-1 modulates invasion in braf-resistant melanomas [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2020 ; 20 1038-1050.[citado 2024 set. 27 ] Available from: https://doi.org/10.2174/1871520620666200218111422
Artigo de periodico
Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance (2020)
Sandria, Silvana; Watanabe, Luis Roberto Masao; Oliveira, Erica Aparecida de; Flores, Fernanda Faião; Migliorini, Silene; Tiago, Manoela; Silva, Aloísio Souza Felipe da; Vazquez, Vinicius de Lima; Souza, Paola da Costa; Consolaro, Marcia Edilaine Lopes ; Campa, Ana ; Maria-Engler, Silvya Stuchi
Source: Pharmacological Research. Unidades: FCF, FM
Subjects: MELANOMA, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDRIA, Silvana et al. Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance. Pharmacological Research, v. 159, p. 1-19 art. 104998, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2020.104998. Acesso em: 27 set. 2024.
APA
Sandria, S., Watanabe, L. R. M., Oliveira, E. A. de, Flores, F. F., Migliorini, S., Tiago, M., et al. (2020). Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance. Pharmacological Research, 159, 1-19 art. 104998. doi:10.1016/j.phrs.2020.104998
NLM
Sandria S, Watanabe LRM, Oliveira EA de, Flores FF, Migliorini S, Tiago M, Silva ASF da, Vazquez V de L, Souza P da C, Consolaro MEL, Campa A, Maria-Engler SS. Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance [Internet]. Pharmacological Research. 2020 ; 159 1-19 art. 104998.[citado 2024 set. 27 ] Available from: https://doi.org/10.1016/j.phrs.2020.104998
Vancouver
Sandria S, Watanabe LRM, Oliveira EA de, Flores FF, Migliorini S, Tiago M, Silva ASF da, Vazquez V de L, Souza P da C, Consolaro MEL, Campa A, Maria-Engler SS. Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance [Internet]. Pharmacological Research. 2020 ; 159 1-19 art. 104998.[citado 2024 set. 27 ] Available from: https://doi.org/10.1016/j.phrs.2020.104998
Artigo de periodico
Air particulate matter induces skin barrier dysfunction and water transport alteration on a reconstructed human epidermis model (2020)
Hieda, Daniele Seo ; Carvalho, Larissa Anastácio da Costa ; Mello, Barbara Vaz de ; Oliveira, Erica Aparecida de ; Assis, Sílvia Romano de ; Wu, Joanna ; Du-Thumm, Laurence ; Silva, Claudia Larissa Viana da ; Roubicek, Deborah Arnsdorff ; Maria-Engler, Silvya Stuchi ; Barros, Silvia Berlanga de Moraes
Source: Journal of Investigative Dermatology. Unidade: FCF
Subjects: PELE, POLUIÇÃO ATMOSFÉRICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIEDA, Daniele Seo et al. Air particulate matter induces skin barrier dysfunction and water transport alteration on a reconstructed human epidermis model. Journal of Investigative Dermatology, v. 140, n. 12, p. 2343-2352, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jid.2020.03.971. Acesso em: 27 set. 2024.
APA
Hieda, D. S., Carvalho, L. A. da C., Mello, B. V. de, Oliveira, E. A. de, Assis, S. R. de, Wu, J., et al. (2020). Air particulate matter induces skin barrier dysfunction and water transport alteration on a reconstructed human epidermis model. Journal of Investigative Dermatology, 140( 12), 2343-2352. doi:10.1016/j.jid.2020.03.971
NLM
Hieda DS, Carvalho LA da C, Mello BV de, Oliveira EA de, Assis SR de, Wu J, Du-Thumm L, Silva CLV da, Roubicek DA, Maria-Engler SS, Barros SB de M. Air particulate matter induces skin barrier dysfunction and water transport alteration on a reconstructed human epidermis model [Internet]. Journal of Investigative Dermatology. 2020 ; 140( 12): 2343-2352.[citado 2024 set. 27 ] Available from: https://doi.org/10.1016/j.jid.2020.03.971
Vancouver
Hieda DS, Carvalho LA da C, Mello BV de, Oliveira EA de, Assis SR de, Wu J, Du-Thumm L, Silva CLV da, Roubicek DA, Maria-Engler SS, Barros SB de M. Air particulate matter induces skin barrier dysfunction and water transport alteration on a reconstructed human epidermis model [Internet]. Journal of Investigative Dermatology. 2020 ; 140( 12): 2343-2352.[citado 2024 set. 27 ] Available from: https://doi.org/10.1016/j.jid.2020.03.971
Artigo de periodico
Effect of nanoemulsion modification with chitosan and sodium alginate on the topical delivery and efficacy of the cytotoxic agent piplartine in 2D and 3D skin cancer models (2020)
Giacone, Daniela Veronesi ; Dartora, Vanessa Franco Carvalho ; Matos, Jenyffer Kelly Rocha De ; Passos, Julia Sapienza ; Miranda, Daniel Augusto Gomes ; Oliveira, Erica Aparecida de ; Silveira, Edilberto R. ; Costa-Lotufo, Letícia Veras ; Maria-Engler, Silvya Stuchi ; Lopes, Luciana Biagini
Source: Journal of Biological Macromolecules. Unidades: ICB, FCF
Subjects: NEOPLASIAS, NEOPLASIAS EMBRIONÁRIAS DE CÉLULAS GERMINATIVAS, PELE, ALGINATOS, MELANOMA, QUITOSANA, POLISSACARÍDEOS, CITOTOXINAS, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIACONE, Daniela Veronesi et al. Effect of nanoemulsion modification with chitosan and sodium alginate on the topical delivery and efficacy of the cytotoxic agent piplartine in 2D and 3D skin cancer models. Journal of Biological Macromolecules, v. 165, p. 1055-1065, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ijbiomac.2020.09.167. Acesso em: 27 set. 2024.
APA
Giacone, D. V., Dartora, V. F. C., Matos, J. K. R. D., Passos, J. S., Miranda, D. A. G., Oliveira, E. A. de, et al. (2020). Effect of nanoemulsion modification with chitosan and sodium alginate on the topical delivery and efficacy of the cytotoxic agent piplartine in 2D and 3D skin cancer models. Journal of Biological Macromolecules, 165, 1055-1065. doi:10.1016/j.ijbiomac.2020.09.167
NLM
Giacone DV, Dartora VFC, Matos JKRD, Passos JS, Miranda DAG, Oliveira EA de, Silveira ER, Costa-Lotufo LV, Maria-Engler SS, Lopes LB. Effect of nanoemulsion modification with chitosan and sodium alginate on the topical delivery and efficacy of the cytotoxic agent piplartine in 2D and 3D skin cancer models [Internet]. Journal of Biological Macromolecules. 2020 ; 165 1055-1065.[citado 2024 set. 27 ] Available from: https://doi.org/10.1016/j.ijbiomac.2020.09.167
Vancouver
Giacone DV, Dartora VFC, Matos JKRD, Passos JS, Miranda DAG, Oliveira EA de, Silveira ER, Costa-Lotufo LV, Maria-Engler SS, Lopes LB. Effect of nanoemulsion modification with chitosan and sodium alginate on the topical delivery and efficacy of the cytotoxic agent piplartine in 2D and 3D skin cancer models [Internet]. Journal of Biological Macromolecules. 2020 ; 165 1055-1065.[citado 2024 set. 27 ] Available from: https://doi.org/10.1016/j.ijbiomac.2020.09.167
Artigo de periodico
ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC) (2019)
Fernandes, Débora Kristina Alves; Oliveira, Erica Aparecida de; Flores, Fernanda Faião; Rebecca, Gretchen Alicea; Weeraratna, Ashani T; Smalley, Keiran S. M; Barros, Silvia Berlanga de Moraes ; Maria-Engler, Silvya Stuchi
Source: Pharmacological Research. Unidade: FCF
Subjects: MELANOMA, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Débora Kristina Alves et al. ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC). Pharmacological Research, v. 141, p. 63-72, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2018.12.006. Acesso em: 27 set. 2024.
APA
Fernandes, D. K. A., Oliveira, E. A. de, Flores, F. F., Rebecca, G. A., Weeraratna, A. T., Smalley, K. S. M., et al. (2019). ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC). Pharmacological Research, 141, 63-72. doi:10.1016/j.phrs.2018.12.006
NLM
Fernandes DKA, Oliveira EA de, Flores FF, Rebecca GA, Weeraratna AT, Smalley KSM, Barros SB de M, Maria-Engler SS. ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC) [Internet]. Pharmacological Research. 2019 ; 141 63-72.[citado 2024 set. 27 ] Available from: https://doi.org/10.1016/j.phrs.2018.12.006
Vancouver
Fernandes DKA, Oliveira EA de, Flores FF, Rebecca GA, Weeraratna AT, Smalley KSM, Barros SB de M, Maria-Engler SS. ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC) [Internet]. Pharmacological Research. 2019 ; 141 63-72.[citado 2024 set. 27 ] Available from: https://doi.org/10.1016/j.phrs.2018.12.006
Trabalho de evento-resumo
TOP1 as a molecular signature in melanoma progression and resistance to BRAF and MEK inhibitors (2018)
Oliveira, Erica Aparecida de; Fernandes, Débora Kristina Alves; Watanabe, Luis Roberto Masao; Consolaro, Márcia Edilaine Lopes; Maria-Engler, Silvya Stuchi
Source: Resumos. Conference titles: International Symposium on Pathophysiology and Toxicology/ISPAT. Unidade: FCF
Subjects: MELANOMA, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Erica Aparecida de et al. TOP1 as a molecular signature in melanoma progression and resistance to BRAF and MEK inhibitors. 2018, Anais.. São Paulo: FCF/USP, 2018. Disponível em: http://simpac.wixsite.com/simpac/symposium-publications. Acesso em: 27 set. 2024.
APA
Oliveira, E. A. de, Fernandes, D. K. A., Watanabe, L. R. M., Consolaro, M. E. L., & Maria-Engler, S. S. (2018). TOP1 as a molecular signature in melanoma progression and resistance to BRAF and MEK inhibitors. In Resumos. São Paulo: FCF/USP. Recuperado de http://simpac.wixsite.com/simpac/symposium-publications
NLM
Oliveira EA de, Fernandes DKA, Watanabe LRM, Consolaro MEL, Maria-Engler SS. TOP1 as a molecular signature in melanoma progression and resistance to BRAF and MEK inhibitors [Internet]. Resumos. 2018 ;[citado 2024 set. 27 ] Available from: http://simpac.wixsite.com/simpac/symposium-publications
Vancouver
Oliveira EA de, Fernandes DKA, Watanabe LRM, Consolaro MEL, Maria-Engler SS. TOP1 as a molecular signature in melanoma progression and resistance to BRAF and MEK inhibitors [Internet]. Resumos. 2018 ;[citado 2024 set. 27 ] Available from: http://simpac.wixsite.com/simpac/symposium-publications
Trabalho de evento-resumo periodico
Indoleamine 2 3-dioxygenase (IDO) enzyme can contributes to the resistance of human melanoma naïve and resistant to BRAF inhibitor (2018)
Watanabe, Luis Roberto Masao; Oliveira, Erica Aparecida de; Sandri, Silvana; Consolaro, Marcia Edilaine Lopes; Campa, Ana ; Maria-Engler, Silvya Stuchi
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Congress of the Brazilian Association of Pharmaceutical Sciences/ABCF. Unidade: FCF
Subjects: MELANOMA, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WATANABE, Luis Roberto Masao et al. Indoleamine 2 3-dioxygenase (IDO) enzyme can contributes to the resistance of human melanoma naïve and resistant to BRAF inhibitor. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf. Acesso em: 27 set. 2024. , 2018
APA
Watanabe, L. R. M., Oliveira, E. A. de, Sandri, S., Consolaro, M. E. L., Campa, A., & Maria-Engler, S. S. (2018). Indoleamine 2 3-dioxygenase (IDO) enzyme can contributes to the resistance of human melanoma naïve and resistant to BRAF inhibitor. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
NLM
Watanabe LRM, Oliveira EA de, Sandri S, Consolaro MEL, Campa A, Maria-Engler SS. Indoleamine 2 3-dioxygenase (IDO) enzyme can contributes to the resistance of human melanoma naïve and resistant to BRAF inhibitor [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 31 res. 221.[citado 2024 set. 27 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
Vancouver
Watanabe LRM, Oliveira EA de, Sandri S, Consolaro MEL, Campa A, Maria-Engler SS. Indoleamine 2 3-dioxygenase (IDO) enzyme can contributes to the resistance of human melanoma naïve and resistant to BRAF inhibitor [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 31 res. 221.[citado 2024 set. 27 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
Trabalho de evento-resumo
Indoleamine 2 3-dioxygenase (IDO) enzyme can contributes to the resistance of human melanoma naïve and resistant to BRAF inhibitor (2018)
Watanabe, Luis Roberto Masao; Oliveira, Erica Aparecida de; Sandri, Silvana; Consolaro, Márcia Edilaine Lopes; Campa, Ana ; Maria-Engler, Silvya Stuchi
Source: Resumos. Conference titles: International Symposium on Pathophysiology and Toxicology/ISPAT. Unidade: FCF
Subjects: MELANOMA, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WATANABE, Luis Roberto Masao et al. Indoleamine 2 3-dioxygenase (IDO) enzyme can contributes to the resistance of human melanoma naïve and resistant to BRAF inhibitor. 2018, Anais.. São Paulo: FCF/USP, 2018. Disponível em: http://simpac.wixsite.com/simpac/symposium-publications. Acesso em: 27 set. 2024.
APA
Watanabe, L. R. M., Oliveira, E. A. de, Sandri, S., Consolaro, M. E. L., Campa, A., & Maria-Engler, S. S. (2018). Indoleamine 2 3-dioxygenase (IDO) enzyme can contributes to the resistance of human melanoma naïve and resistant to BRAF inhibitor. In Resumos. São Paulo: FCF/USP. Recuperado de http://simpac.wixsite.com/simpac/symposium-publications
NLM
Watanabe LRM, Oliveira EA de, Sandri S, Consolaro MEL, Campa A, Maria-Engler SS. Indoleamine 2 3-dioxygenase (IDO) enzyme can contributes to the resistance of human melanoma naïve and resistant to BRAF inhibitor [Internet]. Resumos. 2018 ;[citado 2024 set. 27 ] Available from: http://simpac.wixsite.com/simpac/symposium-publications
Vancouver
Watanabe LRM, Oliveira EA de, Sandri S, Consolaro MEL, Campa A, Maria-Engler SS. Indoleamine 2 3-dioxygenase (IDO) enzyme can contributes to the resistance of human melanoma naïve and resistant to BRAF inhibitor [Internet]. Resumos. 2018 ;[citado 2024 set. 27 ] Available from: http://simpac.wixsite.com/simpac/symposium-publications
Trabalho de evento-resumo
ADK inhibitor is a potent antiproliferative agent in naïve and resistant to BRAF inhibitor human melanomas (2018)
Santos, Stephanie Cristine Carvalho dos; Oliveira, Erica Aparecida de; Maria-Engler, Silvya Stuchi
Source: Resumos. Conference titles: International Symposium on Pathophysiology and Toxicology/ISPAT. Unidade: FCF
Subjects: MELANOMA, CITOTOXICIDADE IMUNOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Stephanie Cristine Carvalho dos e OLIVEIRA, Erica Aparecida de e MARIA-ENGLER, Silvya Stuchi. ADK inhibitor is a potent antiproliferative agent in naïve and resistant to BRAF inhibitor human melanomas. 2018, Anais.. São Paulo: FCF/USP, 2018. Disponível em: http://simpac.wixsite.com/simpac/symposium-publications. Acesso em: 27 set. 2024.
APA
Santos, S. C. C. dos, Oliveira, E. A. de, & Maria-Engler, S. S. (2018). ADK inhibitor is a potent antiproliferative agent in naïve and resistant to BRAF inhibitor human melanomas. In Resumos. São Paulo: FCF/USP. Recuperado de http://simpac.wixsite.com/simpac/symposium-publications
NLM
Santos SCC dos, Oliveira EA de, Maria-Engler SS. ADK inhibitor is a potent antiproliferative agent in naïve and resistant to BRAF inhibitor human melanomas [Internet]. Resumos. 2018 ;[citado 2024 set. 27 ] Available from: http://simpac.wixsite.com/simpac/symposium-publications
Vancouver
Santos SCC dos, Oliveira EA de, Maria-Engler SS. ADK inhibitor is a potent antiproliferative agent in naïve and resistant to BRAF inhibitor human melanomas [Internet]. Resumos. 2018 ;[citado 2024 set. 27 ] Available from: http://simpac.wixsite.com/simpac/symposium-publications
Trabalho de evento-resumo periodico
SIN3B: possible role in melanoma resistance and progression (2018)
Sekimoto, Larissa Satiko Alcântara; Oliveira, Erica Aparecida de; Jorge, Natasha Andressa Nogueira; Possik, Patricia Abrão; Maria-Engler, Silvya Stuchi
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Congress of the Brazilian Association of Pharmaceutical Sciences/ABCF. Unidade: FCF
Assunto: MELANOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEKIMOTO, Larissa Satiko Alcântara et al. SIN3B: possible role in melanoma resistance and progression. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf. Acesso em: 27 set. 2024. , 2018
APA
Sekimoto, L. S. A., Oliveira, E. A. de, Jorge, N. A. N., Possik, P. A., & Maria-Engler, S. S. (2018). SIN3B: possible role in melanoma resistance and progression. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
NLM
Sekimoto LSA, Oliveira EA de, Jorge NAN, Possik PA, Maria-Engler SS. SIN3B: possible role in melanoma resistance and progression [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 29 res. 113.[citado 2024 set. 27 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
Vancouver
Sekimoto LSA, Oliveira EA de, Jorge NAN, Possik PA, Maria-Engler SS. SIN3B: possible role in melanoma resistance and progression [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 29 res. 113.[citado 2024 set. 27 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
Trabalho de evento-resumo
Integrative toxicogenomic and system biology platforms to target melanoma genes by DM-1 (2016)
Oliveira, Erica Aparecida de; Souza, Garcia Ferreira de; Lima, Diógenes Saulo de; Cardozo, Lucas Esteves; Faião-Flores, Fernanda; Suárez, José Agustín Pablo Quincoces; Nakaya, Helder Takashi Imoto ; Monteiro, Gisele ; Maria-Engler, Silvya Stuchi
Source: Resumos. Conference titles: Congresso da Sociedade Brasileira de Biologia Celular. Unidade: FCF
Subjects: MELANOMA, SACCHAROMYCES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Erica Aparecida de et al. Integrative toxicogenomic and system biology platforms to target melanoma genes by DM-1. 2016, Anais.. São Paulo: Sociedade Brasileira de Biologia Celular (SBBC), 2016. . Acesso em: 27 set. 2024.
APA
Oliveira, E. A. de, Souza, G. F. de, Lima, D. S. de, Cardozo, L. E., Faião-Flores, F., Suárez, J. A. P. Q., et al. (2016). Integrative toxicogenomic and system biology platforms to target melanoma genes by DM-1. In Resumos. São Paulo: Sociedade Brasileira de Biologia Celular (SBBC).
NLM
Oliveira EA de, Souza GF de, Lima DS de, Cardozo LE, Faião-Flores F, Suárez JAPQ, Nakaya HTI, Monteiro G, Maria-Engler SS. Integrative toxicogenomic and system biology platforms to target melanoma genes by DM-1. Resumos. 2016 ;[citado 2024 set. 27 ]
Vancouver
Oliveira EA de, Souza GF de, Lima DS de, Cardozo LE, Faião-Flores F, Suárez JAPQ, Nakaya HTI, Monteiro G, Maria-Engler SS. Integrative toxicogenomic and system biology platforms to target melanoma genes by DM-1. Resumos. 2016 ;[citado 2024 set. 27 ]
Trabalho de evento-resumo periodico
REPIN-1 as a tumoral marker in cervical cancer (2016)
Valentini, Vanessa; Oliveira, Erica Aparecida de; Maria-Engler, Silvya Stuchi
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALENTINI, Vanessa e OLIVEIRA, Erica Aparecida de e MARIA-ENGLER, Silvya Stuchi. REPIN-1 as a tumoral marker in cervical cancer. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 27 set. 2024. , 2016
APA
Valentini, V., Oliveira, E. A. de, & Maria-Engler, S. S. (2016). REPIN-1 as a tumoral marker in cervical cancer. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Valentini V, Oliveira EA de, Maria-Engler SS. REPIN-1 as a tumoral marker in cervical cancer. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 42 res. FCF079.[citado 2024 set. 27 ]
Vancouver
Valentini V, Oliveira EA de, Maria-Engler SS. REPIN-1 as a tumoral marker in cervical cancer. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 42 res. FCF079.[citado 2024 set. 27 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Countries/Territories

Funding Agencies

Non normalized affiliation